Experimental studies on viscofluids for intraocular surgery
Identifieur interne : 002402 ( Istex/Corpus ); précédent : 002401; suivant : 002403Experimental studies on viscofluids for intraocular surgery
Auteurs : Ehud I. Assia ; Meir Yehezkel ; Nathan Ezov ; Giora Treister ; Michael BlumenthalSource :
- Journal of Cataract & Refractive Surgery [ 0886-3350 ] ; 1998.
Abstract
Purpose: To investigate the feasibility and efficacy of using diluted viscofluids during intraocular surgery.Setting: Laboratory for Intraocular Microsurgery and Implants, Goldschleger -Eye Research Institute, and the Sackler School of Medicine, Tel-Hashomer, Israel.Methods: Diluted hyaluronic acid (0.06 to 0.12%) in balanced salt solutions were irrigated through the phacoemulsification machine or a separate irrigation line (i.e., anterior chamber maintainer). Irrigation was facilitated by increasing the atmospheric pressure in the bottle using compressed air. Experimental surgery was done in rabbit eyes.Results: A viscous fluid could be irrigated at any practical rate by increasing the height of the bottle, increasing the atmospheric pressure within the bottle, or both. Experimental surgeries showed that viscofluids maintained intraocular pressure and anterior chamber volume, allowed safe intraocular manipulations, reduced turbulence in the anterior chamber, and probably provided tissue protection.Conclusion: Viscofluids irrigated using a high-pressure system combined the advantages of continuous irrigation of fluids and the protective qualities of viscoelastics in this rabbit eye study.
Url:
DOI: 10.1016/S0886-3350(98)80078-3
Links to Exploration step
ISTEX:7F9073FB9E28EF28B38E74613117D2E9319BDB0DLe document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Experimental studies on viscofluids for intraocular surgery</title><author><name sortKey="Assia, Ehud I" sort="Assia, Ehud I" uniqKey="Assia E" first="Ehud I." last="Assia">Ehud I. Assia</name><affiliation><mods:affiliation>From the Department of Ophthalmology, Meir Hospital, Sapir Medical Center, Kfar-Saba</mods:affiliation></affiliation><affiliation><mods:affiliation>Reprint requests to Ehud I. Assia, MD, Director, Department of Ophthalmology, Meir Hospital, Sapir Medical Center, Kfar-Saba 44281, Israel.</mods:affiliation></affiliation></author><author><name sortKey="Yehezkel, Meir" sort="Yehezkel, Meir" uniqKey="Yehezkel M" first="Meir" last="Yehezkel">Meir Yehezkel</name><affiliation><mods:affiliation>From the Department of Ophthalmology, Meir Hospital, Sapir Medical Center, Kfar-Saba</mods:affiliation></affiliation></author><author><name sortKey="Ezov, Nathan" sort="Ezov, Nathan" uniqKey="Ezov N" first="Nathan" last="Ezov">Nathan Ezov</name><affiliation><mods:affiliation>From the Bio-Technology General (Israel) Ltd., Kiryat Weizman, Rehovot</mods:affiliation></affiliation></author><author><name sortKey="Treister, Giora" sort="Treister, Giora" uniqKey="Treister G" first="Giora" last="Treister">Giora Treister</name><affiliation><mods:affiliation>From the Department of Ophthalmology, Goldschleger Eye Institute, Sheba Medical Center, Tel-Hashomer (Treister, Blumenthal), Israel.</mods:affiliation></affiliation></author><author><name sortKey="Blumenthal, Michael" sort="Blumenthal, Michael" uniqKey="Blumenthal M" first="Michael" last="Blumenthal">Michael Blumenthal</name><affiliation><mods:affiliation>From the Department of Ophthalmology, Goldschleger Eye Institute, Sheba Medical Center, Tel-Hashomer (Treister, Blumenthal), Israel.</mods:affiliation></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:7F9073FB9E28EF28B38E74613117D2E9319BDB0D</idno><date when="1998" year="1998">1998</date><idno type="doi">10.1016/S0886-3350(98)80078-3</idno><idno type="url">https://api.istex.fr/document/7F9073FB9E28EF28B38E74613117D2E9319BDB0D/fulltext/pdf</idno><idno type="wicri:Area/Istex/Corpus">002402</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Experimental studies on viscofluids for intraocular surgery</title><author><name sortKey="Assia, Ehud I" sort="Assia, Ehud I" uniqKey="Assia E" first="Ehud I." last="Assia">Ehud I. Assia</name><affiliation><mods:affiliation>From the Department of Ophthalmology, Meir Hospital, Sapir Medical Center, Kfar-Saba</mods:affiliation></affiliation><affiliation><mods:affiliation>Reprint requests to Ehud I. Assia, MD, Director, Department of Ophthalmology, Meir Hospital, Sapir Medical Center, Kfar-Saba 44281, Israel.</mods:affiliation></affiliation></author><author><name sortKey="Yehezkel, Meir" sort="Yehezkel, Meir" uniqKey="Yehezkel M" first="Meir" last="Yehezkel">Meir Yehezkel</name><affiliation><mods:affiliation>From the Department of Ophthalmology, Meir Hospital, Sapir Medical Center, Kfar-Saba</mods:affiliation></affiliation></author><author><name sortKey="Ezov, Nathan" sort="Ezov, Nathan" uniqKey="Ezov N" first="Nathan" last="Ezov">Nathan Ezov</name><affiliation><mods:affiliation>From the Bio-Technology General (Israel) Ltd., Kiryat Weizman, Rehovot</mods:affiliation></affiliation></author><author><name sortKey="Treister, Giora" sort="Treister, Giora" uniqKey="Treister G" first="Giora" last="Treister">Giora Treister</name><affiliation><mods:affiliation>From the Department of Ophthalmology, Goldschleger Eye Institute, Sheba Medical Center, Tel-Hashomer (Treister, Blumenthal), Israel.</mods:affiliation></affiliation></author><author><name sortKey="Blumenthal, Michael" sort="Blumenthal, Michael" uniqKey="Blumenthal M" first="Michael" last="Blumenthal">Michael Blumenthal</name><affiliation><mods:affiliation>From the Department of Ophthalmology, Goldschleger Eye Institute, Sheba Medical Center, Tel-Hashomer (Treister, Blumenthal), Israel.</mods:affiliation></affiliation></author></analytic><monogr></monogr><series><title level="j">Journal of Cataract & Refractive Surgery</title><title level="j" type="abbrev">JCRS</title><idno type="ISSN">0886-3350</idno><imprint><publisher>ELSEVIER</publisher><date type="published" when="1998">1998</date><biblScope unit="volume">24</biblScope><biblScope unit="issue">1</biblScope><biblScope unit="page" from="78">78</biblScope><biblScope unit="page" to="83">83</biblScope></imprint><idno type="ISSN">0886-3350</idno></series><idno type="istex">7F9073FB9E28EF28B38E74613117D2E9319BDB0D</idno><idno type="DOI">10.1016/S0886-3350(98)80078-3</idno><idno type="PII">S0886-3350(98)80078-3</idno><idno type="ArticleID">80078</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0886-3350</idno></seriesStmt></fileDesc><profileDesc><textClass></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Purpose: To investigate the feasibility and efficacy of using diluted viscofluids during intraocular surgery.Setting: Laboratory for Intraocular Microsurgery and Implants, Goldschleger -Eye Research Institute, and the Sackler School of Medicine, Tel-Hashomer, Israel.Methods: Diluted hyaluronic acid (0.06 to 0.12%) in balanced salt solutions were irrigated through the phacoemulsification machine or a separate irrigation line (i.e., anterior chamber maintainer). Irrigation was facilitated by increasing the atmospheric pressure in the bottle using compressed air. Experimental surgery was done in rabbit eyes.Results: A viscous fluid could be irrigated at any practical rate by increasing the height of the bottle, increasing the atmospheric pressure within the bottle, or both. Experimental surgeries showed that viscofluids maintained intraocular pressure and anterior chamber volume, allowed safe intraocular manipulations, reduced turbulence in the anterior chamber, and probably provided tissue protection.Conclusion: Viscofluids irrigated using a high-pressure system combined the advantages of continuous irrigation of fluids and the protective qualities of viscoelastics in this rabbit eye study.</div></front></TEI><istex><corpusName>elsevier</corpusName><author><json:item><name>Ehud I. Assia MD</name><affiliations><json:string>From the Department of Ophthalmology, Meir Hospital, Sapir Medical Center, Kfar-Saba</json:string><json:string>Reprint requests to Ehud I. Assia, MD, Director, Department of Ophthalmology, Meir Hospital, Sapir Medical Center, Kfar-Saba 44281, Israel.</json:string></affiliations></json:item><json:item><name>Meir Yehezkel MD</name><affiliations><json:string>From the Department of Ophthalmology, Meir Hospital, Sapir Medical Center, Kfar-Saba</json:string></affiliations></json:item><json:item><name>Nathan Ezov VetD</name><affiliations><json:string>From the Bio-Technology General (Israel) Ltd., Kiryat Weizman, Rehovot</json:string></affiliations></json:item><json:item><name>Giora Treister MD</name><affiliations><json:string>From the Department of Ophthalmology, Goldschleger Eye Institute, Sheba Medical Center, Tel-Hashomer (Treister, Blumenthal), Israel.</json:string></affiliations></json:item><json:item><name>Michael Blumenthal MD</name><affiliations><json:string>From the Department of Ophthalmology, Goldschleger Eye Institute, Sheba Medical Center, Tel-Hashomer (Treister, Blumenthal), Israel.</json:string></affiliations></json:item></author><articleId><json:string>80078</json:string></articleId><language><json:string>eng</json:string></language><abstract>Purpose: To investigate the feasibility and efficacy of using diluted viscofluids during intraocular surgery.Setting: Laboratory for Intraocular Microsurgery and Implants, Goldschleger -Eye Research Institute, and the Sackler School of Medicine, Tel-Hashomer, Israel.Methods: Diluted hyaluronic acid (0.06 to 0.12%) in balanced salt solutions were irrigated through the phacoemulsification machine or a separate irrigation line (i.e., anterior chamber maintainer). Irrigation was facilitated by increasing the atmospheric pressure in the bottle using compressed air. Experimental surgery was done in rabbit eyes.Results: A viscous fluid could be irrigated at any practical rate by increasing the height of the bottle, increasing the atmospheric pressure within the bottle, or both. Experimental surgeries showed that viscofluids maintained intraocular pressure and anterior chamber volume, allowed safe intraocular manipulations, reduced turbulence in the anterior chamber, and probably provided tissue protection.Conclusion: Viscofluids irrigated using a high-pressure system combined the advantages of continuous irrigation of fluids and the protective qualities of viscoelastics in this rabbit eye study.</abstract><qualityIndicators><score>6.887</score><pdfVersion>1.7</pdfVersion><pdfPageSize>576 x 828 pts</pdfPageSize><refBibsNative>true</refBibsNative><keywordCount>0</keywordCount><abstractCharCount>1207</abstractCharCount><pdfWordCount>3015</pdfWordCount><pdfCharCount>19131</pdfCharCount><pdfPageCount>6</pdfPageCount><abstractWordCount>156</abstractWordCount></qualityIndicators><title>Experimental studies on viscofluids for intraocular surgery</title><pii><json:string>S0886-3350(98)80078-3</json:string></pii><genre><json:string>research-article</json:string></genre><host><volume>24</volume><pii><json:string>S0886-3350(98)X8058-2</json:string></pii><pages><last>83</last><first>78</first></pages><issn><json:string>0886-3350</json:string></issn><issue>1</issue><genre><json:string>Journal</json:string></genre><language><json:string>unknown</json:string></language><title>Journal of Cataract & Refractive Surgery</title><publicationDate>1998</publicationDate></host><categories><wos><json:string>OPHTHALMOLOGY</json:string><json:string>SURGERY</json:string></wos></categories><publicationDate>1998</publicationDate><copyrightDate>1998</copyrightDate><doi><json:string>10.1016/S0886-3350(98)80078-3</json:string></doi><id>7F9073FB9E28EF28B38E74613117D2E9319BDB0D</id><score>1</score><fulltext><json:item><original>true</original><mimetype>application/pdf</mimetype><extension>pdf</extension><uri>https://api.istex.fr/document/7F9073FB9E28EF28B38E74613117D2E9319BDB0D/fulltext/pdf</uri></json:item><json:item><original>true</original><mimetype>text/plain</mimetype><extension>txt</extension><uri>https://api.istex.fr/document/7F9073FB9E28EF28B38E74613117D2E9319BDB0D/fulltext/txt</uri></json:item><json:item><original>false</original><mimetype>application/zip</mimetype><extension>zip</extension><uri>https://api.istex.fr/document/7F9073FB9E28EF28B38E74613117D2E9319BDB0D/fulltext/zip</uri></json:item><istex:fulltextTEI uri="https://api.istex.fr/document/7F9073FB9E28EF28B38E74613117D2E9319BDB0D/fulltext/tei"><teiHeader><fileDesc><titleStmt><title level="a" type="main" xml:lang="en">Experimental studies on viscofluids for intraocular surgery</title></titleStmt><publicationStmt><authority>ISTEX</authority><publisher>ELSEVIER</publisher><availability><p>ELSEVIER</p></availability><date>1998</date></publicationStmt><sourceDesc><biblStruct type="inbook"><analytic><title level="a" type="main" xml:lang="en">Experimental studies on viscofluids for intraocular surgery</title><author><persName><forename type="first">Ehud I.</forename><surname>Assia</surname></persName><roleName type="degree">MD</roleName><affiliation>From the Department of Ophthalmology, Meir Hospital, Sapir Medical Center, Kfar-Saba</affiliation><affiliation>Reprint requests to Ehud I. Assia, MD, Director, Department of Ophthalmology, Meir Hospital, Sapir Medical Center, Kfar-Saba 44281, Israel.</affiliation></author><author><persName><forename type="first">Meir</forename><surname>Yehezkel</surname></persName><roleName type="degree">MD</roleName><affiliation>From the Department of Ophthalmology, Meir Hospital, Sapir Medical Center, Kfar-Saba</affiliation></author><author><persName><forename type="first">Nathan</forename><surname>Ezov</surname></persName><roleName type="degree">VetD</roleName><affiliation>From the Bio-Technology General (Israel) Ltd., Kiryat Weizman, Rehovot</affiliation></author><author><persName><forename type="first">Giora</forename><surname>Treister</surname></persName><roleName type="degree">MD</roleName><affiliation>From the Department of Ophthalmology, Goldschleger Eye Institute, Sheba Medical Center, Tel-Hashomer (Treister, Blumenthal), Israel.</affiliation></author><author><persName><forename type="first">Michael</forename><surname>Blumenthal</surname></persName><roleName type="degree">MD</roleName><affiliation>From the Department of Ophthalmology, Goldschleger Eye Institute, Sheba Medical Center, Tel-Hashomer (Treister, Blumenthal), Israel.</affiliation></author></analytic><monogr><title level="j">Journal of Cataract & Refractive Surgery</title><title level="j" type="abbrev">JCRS</title><idno type="pISSN">0886-3350</idno><idno type="PII">S0886-3350(98)X8058-2</idno><imprint><publisher>ELSEVIER</publisher><date type="published" when="1998"></date><biblScope unit="volume">24</biblScope><biblScope unit="issue">1</biblScope><biblScope unit="page" from="78">78</biblScope><biblScope unit="page" to="83">83</biblScope></imprint></monogr><idno type="istex">7F9073FB9E28EF28B38E74613117D2E9319BDB0D</idno><idno type="DOI">10.1016/S0886-3350(98)80078-3</idno><idno type="PII">S0886-3350(98)80078-3</idno><idno type="ArticleID">80078</idno></biblStruct></sourceDesc></fileDesc><profileDesc><creation><date>1998</date></creation><langUsage><language ident="en">en</language></langUsage><abstract xml:lang="en"><p>Purpose: To investigate the feasibility and efficacy of using diluted viscofluids during intraocular surgery.Setting: Laboratory for Intraocular Microsurgery and Implants, Goldschleger -Eye Research Institute, and the Sackler School of Medicine, Tel-Hashomer, Israel.Methods: Diluted hyaluronic acid (0.06 to 0.12%) in balanced salt solutions were irrigated through the phacoemulsification machine or a separate irrigation line (i.e., anterior chamber maintainer). Irrigation was facilitated by increasing the atmospheric pressure in the bottle using compressed air. Experimental surgery was done in rabbit eyes.Results: A viscous fluid could be irrigated at any practical rate by increasing the height of the bottle, increasing the atmospheric pressure within the bottle, or both. Experimental surgeries showed that viscofluids maintained intraocular pressure and anterior chamber volume, allowed safe intraocular manipulations, reduced turbulence in the anterior chamber, and probably provided tissue protection.Conclusion: Viscofluids irrigated using a high-pressure system combined the advantages of continuous irrigation of fluids and the protective qualities of viscoelastics in this rabbit eye study.</p></abstract></profileDesc><revisionDesc><change when="1998">Published</change></revisionDesc></teiHeader></istex:fulltextTEI></fulltext><metadata><istex:metadataXml wicri:clean="Elsevier doc found" wicri:toSee="Elsevier, no converted or simple article"><istex:xmlDeclaration>version="1.0" encoding="UTF-8" </istex:xmlDeclaration><istex:docType PUBLIC="-//ES//DTD journal article DTD version 5.2.0//EN//XML" URI="art520.dtd" name="istex:docType"></istex:docType><istex:document><article version="5.2" xml:lang="en" docsubtype="fla"><item-info><jid>JCRS</jid><aid>80078</aid><ce:pii>S0886-3350(98)80078-3</ce:pii><ce:doi>10.1016/S0886-3350(98)80078-3</ce:doi><ce:copyright type="society" year="1998">American Society of Cataract and Refractive Surgery and European Society of Cataract and Refractive Surgeons. All rights reserved</ce:copyright><ce:copyright-line>Copyright 1998 American Society of Cataract and Refractive Surgery and European Society of Cataract and Refractive Surgeons. All rights reserved</ce:copyright-line></item-info><head><ce:title id="ttl005">Experimental studies on viscofluids for intraocular surgery</ce:title><ce:author-group id="AUG005"><ce:author id="AUT005"><ce:given-name>Ehud I.</ce:given-name><ce:surname>Assia</ce:surname><ce:degrees>MD</ce:degrees><ce:cross-ref id="crr005" refid="aff1"><ce:sup>1</ce:sup></ce:cross-ref><ce:cross-ref id="crr010" refid="cor1"><ce:sup>*</ce:sup></ce:cross-ref></ce:author><ce:author id="AUT010"><ce:given-name>Meir</ce:given-name><ce:surname>Yehezkel</ce:surname><ce:degrees>MD</ce:degrees><ce:cross-ref id="crr015" refid="aff1"><ce:sup>1</ce:sup></ce:cross-ref></ce:author><ce:author id="AUT015"><ce:given-name>Nathan</ce:given-name><ce:surname>Ezov</ce:surname><ce:degrees>VetD</ce:degrees><ce:cross-ref id="crr020" refid="aff2"><ce:sup>2</ce:sup></ce:cross-ref></ce:author><ce:author id="AUT020"><ce:given-name>Giora</ce:given-name><ce:surname>Treister</ce:surname><ce:degrees>MD</ce:degrees><ce:cross-ref id="crr025" refid="aff3"><ce:sup>3</ce:sup></ce:cross-ref></ce:author><ce:author id="AUT025"><ce:given-name>Michael</ce:given-name><ce:surname>Blumenthal</ce:surname><ce:degrees>MD</ce:degrees><ce:cross-ref id="crr030" refid="aff3"><ce:sup>3</ce:sup></ce:cross-ref></ce:author><ce:affiliation id="aff1"><ce:label>1</ce:label><ce:textfn>From the Department of Ophthalmology, Meir Hospital, Sapir Medical Center, Kfar-Saba</ce:textfn><sa:affiliation><sa:organization>Department of Ophthalmology</sa:organization><sa:organization>Meir Hospital</sa:organization><sa:organization>Sapir Medical Center</sa:organization><sa:city>Kfar-Saba</sa:city></sa:affiliation></ce:affiliation><ce:affiliation id="aff2"><ce:label>2</ce:label><ce:textfn>From the Bio-Technology General (Israel) Ltd., Kiryat Weizman, Rehovot</ce:textfn><sa:affiliation><sa:organization>Bio-Technology General (Israel) Ltd.</sa:organization><sa:address-line>Kiryat Weizman</sa:address-line><sa:city>Rehovot</sa:city></sa:affiliation></ce:affiliation><ce:affiliation id="aff3"><ce:label>3</ce:label><ce:textfn>From the Department of Ophthalmology, Goldschleger Eye Institute, Sheba Medical Center, Tel-Hashomer (Treister, Blumenthal), Israel.</ce:textfn><sa:affiliation><sa:organization>Department of Ophthalmology</sa:organization><sa:organization>Goldschleger Eye Institute</sa:organization><sa:organization>Sheba Medical Center</sa:organization><sa:city>Tel-Hashomer</sa:city><sa:country>Israel</sa:country></sa:affiliation></ce:affiliation><ce:correspondence id="cor1"><ce:label>*</ce:label><ce:text>Reprint requests to Ehud I. Assia, MD, Director, Department of Ophthalmology, Meir Hospital, Sapir Medical Center, Kfar-Saba 44281, Israel.</ce:text></ce:correspondence></ce:author-group><ce:abstract id="ab1"><ce:section-title id="SET005">Abstract</ce:section-title><ce:abstract-sec id="abs005"><ce:simple-para id="SP0005"><ce:bold><ce:italic>Purpose:</ce:italic></ce:bold> To investigate the feasibility and efficacy of using diluted viscofluids during intraocular surgery.</ce:simple-para><ce:simple-para id="SP0010"><ce:bold><ce:italic>Setting:</ce:italic></ce:bold> Laboratory for Intraocular Microsurgery and Implants, Goldschleger -Eye Research Institute, and the Sackler School of Medicine, Tel-Hashomer, Israel.</ce:simple-para><ce:simple-para id="SP0015"><ce:bold><ce:italic>Methods:</ce:italic></ce:bold> Diluted hyaluronic acid (0.06 to 0.12%) in balanced salt solutions were irrigated through the phacoemulsification machine or a separate irrigation line (i.e., anterior chamber maintainer). Irrigation was facilitated by increasing the atmospheric pressure in the bottle using compressed air. Experimental surgery was done in rabbit eyes.</ce:simple-para><ce:simple-para id="SP0020"><ce:bold><ce:italic>Results:</ce:italic></ce:bold> A viscous fluid could be irrigated at any practical rate by increasing the height of the bottle, increasing the atmospheric pressure within the bottle, or both. Experimental surgeries showed that viscofluids maintained intraocular pressure and anterior chamber volume, allowed safe intraocular manipulations, reduced turbulence in the anterior chamber, and probably provided tissue protection.</ce:simple-para><ce:simple-para id="SP0025"><ce:bold><ce:italic>Conclusion:</ce:italic></ce:bold> Viscofluids irrigated using a high-pressure system combined the advantages of continuous irrigation of fluids and the protective qualities of viscoelastics in this rabbit eye study.</ce:simple-para></ce:abstract-sec></ce:abstract></head><tail><ce:bibliography id="R0005"><ce:section-title id="SET010">References</ce:section-title><ce:bibliography-sec id="RS0005"><ce:bib-reference id="bib1"><ce:label>1.</ce:label><sb:reference id="SB0005"><sb:contribution><sb:authors><sb:author><ce:given-name>M</ce:given-name><ce:surname>Blumenthal</ce:surname></sb:author><sb:author><ce:given-name>I</ce:given-name><ce:surname>Ashkenazi</ce:surname></sb:author><sb:author><ce:given-name>E</ce:given-name><ce:surname>Assia</ce:surname></sb:author><sb:author><ce:given-name>M</ce:given-name><ce:surname>Cahane</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Smallincision manual extracapsular cataract extraction using selective hydrodissection</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Ophthalmic Surg</sb:maintitle></sb:title><sb:volume-nr>23</sb:volume-nr></sb:series><sb:date>1992</sb:date></sb:issue><sb:pages><sb:first-page>699</sb:first-page><sb:last-page>701</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib2"><ce:label>2.</ce:label><sb:reference id="SB0010"><sb:contribution><sb:authors><sb:author><ce:given-name>M</ce:given-name><ce:surname>Blumenthal</ce:surname></sb:author><sb:author><ce:given-name>El</ce:given-name><ce:surname>Assia</ce:surname></sb:author><sb:author><ce:given-name>V</ce:given-name><ce:surname>Chen</ce:surname></sb:author><sb:author><ce:given-name>I</ce:given-name><ce:surname>Avni</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Using an anterior chamber maintainer to control intraocular pressure during phacoemulsification</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>J Cataract Refract Surg</sb:maintitle></sb:title><sb:volume-nr>20</sb:volume-nr></sb:series><sb:date>1994</sb:date></sb:issue><sb:pages><sb:first-page>93</sb:first-page><sb:last-page>96</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib3"><ce:label>3.</ce:label><sb:reference id="SB0015"><sb:contribution><sb:authors><sb:author><ce:given-name>LG</ce:given-name><ce:surname>Pape</ce:surname></sb:author><sb:author><ce:given-name>EA</ce:given-name><ce:surname>Balazs</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>The use of sodium hyaluronate (Healon®) in human anterior segment surgery</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Ophthalmology</sb:maintitle></sb:title><sb:volume-nr>87</sb:volume-nr></sb:series><sb:date>1980</sb:date></sb:issue><sb:pages><sb:first-page>699</sb:first-page><sb:last-page>705</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib4"><ce:label>4.</ce:label><sb:reference id="SB0020"><sb:contribution><sb:authors><sb:author><ce:given-name>AS</ce:given-name><ce:surname>Holmberg</ce:surname></sb:author><sb:author><ce:given-name>BT</ce:given-name><ce:surname>Philipson</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Sodium hyaluronate in cataract surgery</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>I. Report on the use of Healon® in two different types of intracapsular cataract surgery. Ophthalmology</sb:maintitle></sb:title><sb:volume-nr>91</sb:volume-nr></sb:series><sb:date>1984</sb:date></sb:issue><sb:pages><sb:first-page>45</sb:first-page><sb:last-page>52</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib5"><ce:label>5.</ce:label><sb:reference id="SB0025"><sb:contribution><sb:authors><sb:author><ce:given-name>AS</ce:given-name><ce:surname>Holmberg</ce:surname></sb:author><sb:author><ce:given-name>BT</ce:given-name><ce:surname>Philipson</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Sodium hyaluronate in cataract surgery</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>II. Report on the use of Healon® in extracapsular cataract surgery using phacoemulsification. Ophthalmology</sb:maintitle></sb:title><sb:volume-nr>91</sb:volume-nr></sb:series><sb:date>1984</sb:date></sb:issue><sb:pages><sb:first-page>53</sb:first-page><sb:last-page>59</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib6"><ce:label>6.</ce:label><sb:reference id="SB0030"><sb:contribution><sb:authors><sb:author><ce:given-name>WM</ce:given-name><ce:surname>Bourne</ce:surname></sb:author><sb:author><ce:given-name>TJ</ce:given-name><ce:surname>Liesegang</ce:surname></sb:author><sb:author><ce:given-name>RR</ce:given-name><ce:surname>Waller</ce:surname></sb:author><sb:author><ce:given-name>DM</ce:given-name><ce:surname>Ilstrup</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>The effect of sodium hyaluronate on endothelial cell damage during extracapsular cataract extraction and posterior chamber lens implantation</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Am J Ophthalmol</sb:maintitle></sb:title><sb:volume-nr>98</sb:volume-nr></sb:series><sb:date>1984</sb:date></sb:issue><sb:pages><sb:first-page>759</sb:first-page><sb:last-page>762</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib7"><ce:label>7.</ce:label><sb:reference id="SB0035"><sb:contribution><sb:authors><sb:author><ce:given-name>DB</ce:given-name><ce:surname>Glasser</ce:surname></sb:author><sb:author><ce:given-name>DC</ce:given-name><ce:surname>Osborn</ce:surname></sb:author><sb:author><ce:given-name>JF</ce:given-name><ce:surname>Nordeen</ce:surname></sb:author><sb:author><ce:given-name>YI</ce:given-name><ce:surname>Min</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Endothelial protection and viscoelastic retention during phacoemulsification and intraocular lens implantation</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Arch Ophthalmol</sb:maintitle></sb:title><sb:volume-nr>109</sb:volume-nr></sb:series><sb:date>1991</sb:date></sb:issue><sb:pages><sb:first-page>1438</sb:first-page><sb:last-page>1440</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib8"><ce:label>8.</ce:label><sb:reference id="SB0040"><sb:contribution><sb:authors><sb:author><ce:given-name>El</ce:given-name><ce:surname>Assia</ce:surname></sb:author><sb:author><ce:given-name>M</ce:given-name><ce:surname>Blumenthal</ce:surname></sb:author><sb:author><ce:given-name>DJ</ce:given-name><ce:surname>Apple</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Hydrodissection and viscoextraction of the nucleus in planned extracapsular cataract extraction</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Eur J Implant Refract Surg</sb:maintitle></sb:title><sb:volume-nr>4</sb:volume-nr></sb:series><sb:date>1992</sb:date></sb:issue><sb:pages><sb:first-page>3</sb:first-page><sb:last-page>8</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib9"><ce:label>9.</ce:label><sb:reference id="SB0045"><sb:contribution><sb:authors><sb:author><ce:given-name>S</ce:given-name><ce:surname>Stenkula</ce:surname></sb:author><sb:author><ce:given-name>L</ce:given-name><ce:surname>Ivert</ce:surname></sb:author><sb:author><ce:given-name>L</ce:given-name><ce:surname>Berglin</ce:surname></sb:author><sb:author><ce:given-name>S</ce:given-name><ce:surname>Crafoord</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Healon Yellow as a surgical tool in maneuvering intraocular tissues</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Ophthalmic Surg</sb:maintitle></sb:title><sb:volume-nr>23</sb:volume-nr></sb:series><sb:date>1992</sb:date></sb:issue><sb:pages><sb:first-page>708</sb:first-page><sb:last-page>710</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib10"><ce:label>10.</ce:label><sb:reference id="SB0050"><sb:contribution><sb:authors><sb:author><ce:given-name>EI</ce:given-name><ce:surname>Assia</ce:surname></sb:author><sb:author><ce:given-name>DJ</ce:given-name><ce:surname>Apple</ce:surname></sb:author><sb:author><ce:given-name>ES</ce:given-name><ce:surname>Lim</ce:surname></sb:author><sb:et-al></sb:et-al></sb:authors><sb:title><sb:maintitle>Removal of viscoelastic materials after experimental cataract surgery in vitro</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>J Cataract Refract Surg</sb:maintitle></sb:title><sb:volume-nr>18</sb:volume-nr></sb:series><sb:date>1992</sb:date></sb:issue><sb:pages><sb:first-page>3</sb:first-page><sb:last-page>6</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib11"><ce:label>11.</ce:label><sb:reference id="SB0055"><sb:contribution><sb:authors><sb:author><ce:given-name>LL</ce:given-name><ce:surname>Fry</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Postoperative intraocular pressure rises: a comparison of Healon, Amvisc, and Viscoat</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>J Cataract Refract Surg</sb:maintitle></sb:title><sb:volume-nr>15</sb:volume-nr></sb:series><sb:date>1989</sb:date></sb:issue><sb:pages><sb:first-page>415</sb:first-page><sb:last-page>420</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference></ce:bibliography-sec></ce:bibliography></tail></article></istex:document></istex:metadataXml><mods version="3.6"><titleInfo lang="en"><title>Experimental studies on viscofluids for intraocular surgery</title></titleInfo><titleInfo type="alternative" lang="en" contentType="CDATA"><title>Experimental studies on viscofluids for intraocular surgery</title></titleInfo><name type="personal"><namePart type="given">Ehud I.</namePart><namePart type="family">Assia</namePart><namePart type="termsOfAddress">MD</namePart><affiliation>From the Department of Ophthalmology, Meir Hospital, Sapir Medical Center, Kfar-Saba</affiliation><affiliation>Reprint requests to Ehud I. Assia, MD, Director, Department of Ophthalmology, Meir Hospital, Sapir Medical Center, Kfar-Saba 44281, Israel.</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Meir</namePart><namePart type="family">Yehezkel</namePart><namePart type="termsOfAddress">MD</namePart><affiliation>From the Department of Ophthalmology, Meir Hospital, Sapir Medical Center, Kfar-Saba</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Nathan</namePart><namePart type="family">Ezov</namePart><namePart type="termsOfAddress">VetD</namePart><affiliation>From the Bio-Technology General (Israel) Ltd., Kiryat Weizman, Rehovot</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Giora</namePart><namePart type="family">Treister</namePart><namePart type="termsOfAddress">MD</namePart><affiliation>From the Department of Ophthalmology, Goldschleger Eye Institute, Sheba Medical Center, Tel-Hashomer (Treister, Blumenthal), Israel.</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Michael</namePart><namePart type="family">Blumenthal</namePart><namePart type="termsOfAddress">MD</namePart><affiliation>From the Department of Ophthalmology, Goldschleger Eye Institute, Sheba Medical Center, Tel-Hashomer (Treister, Blumenthal), Israel.</affiliation><role><roleTerm type="text">author</roleTerm></role></name><typeOfResource>text</typeOfResource><genre type="research-article" displayLabel="Full-length article"></genre><originInfo><publisher>ELSEVIER</publisher><dateIssued encoding="w3cdtf">1998</dateIssued><copyrightDate encoding="w3cdtf">1998</copyrightDate></originInfo><language><languageTerm type="code" authority="iso639-2b">eng</languageTerm><languageTerm type="code" authority="rfc3066">en</languageTerm></language><physicalDescription><internetMediaType>text/html</internetMediaType></physicalDescription><abstract lang="en">Purpose: To investigate the feasibility and efficacy of using diluted viscofluids during intraocular surgery.Setting: Laboratory for Intraocular Microsurgery and Implants, Goldschleger -Eye Research Institute, and the Sackler School of Medicine, Tel-Hashomer, Israel.Methods: Diluted hyaluronic acid (0.06 to 0.12%) in balanced salt solutions were irrigated through the phacoemulsification machine or a separate irrigation line (i.e., anterior chamber maintainer). Irrigation was facilitated by increasing the atmospheric pressure in the bottle using compressed air. Experimental surgery was done in rabbit eyes.Results: A viscous fluid could be irrigated at any practical rate by increasing the height of the bottle, increasing the atmospheric pressure within the bottle, or both. Experimental surgeries showed that viscofluids maintained intraocular pressure and anterior chamber volume, allowed safe intraocular manipulations, reduced turbulence in the anterior chamber, and probably provided tissue protection.Conclusion: Viscofluids irrigated using a high-pressure system combined the advantages of continuous irrigation of fluids and the protective qualities of viscoelastics in this rabbit eye study.</abstract><relatedItem type="host"><titleInfo><title>Journal of Cataract & Refractive Surgery</title></titleInfo><titleInfo type="abbreviated"><title>JCRS</title></titleInfo><genre type="Journal">journal</genre><originInfo><dateIssued encoding="w3cdtf">199801</dateIssued></originInfo><identifier type="ISSN">0886-3350</identifier><identifier type="PII">S0886-3350(98)X8058-2</identifier><part><detail type="volume"><number>24</number><caption>vol.</caption></detail><detail type="issue"><number>1</number><caption>no.</caption></detail><extent unit="issue pages"><start>1</start><end>138</end></extent><extent unit="pages"><start>78</start><end>83</end></extent></part></relatedItem><identifier type="istex">7F9073FB9E28EF28B38E74613117D2E9319BDB0D</identifier><identifier type="DOI">10.1016/S0886-3350(98)80078-3</identifier><identifier type="PII">S0886-3350(98)80078-3</identifier><identifier type="ArticleID">80078</identifier><accessCondition type="use and reproduction" contentType="">© 1998American Society of Cataract and Refractive Surgery and European Society of Cataract and Refractive Surgeons. All rights reserved</accessCondition><recordInfo><recordContentSource>ELSEVIER</recordContentSource><recordOrigin>American Society of Cataract and Refractive Surgery and European Society of Cataract and Refractive Surgeons. All rights reserved, ©1998</recordOrigin></recordInfo></mods></metadata><enrichments><istex:catWosTEI uri="https://api.istex.fr/document/7F9073FB9E28EF28B38E74613117D2E9319BDB0D/enrichments/catWos"><teiHeader><profileDesc><textClass><classCode scheme="WOS">OPHTHALMOLOGY</classCode><classCode scheme="WOS">SURGERY</classCode></textClass></profileDesc></teiHeader></istex:catWosTEI></enrichments><serie></serie></istex></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Ticri/CIDE/explor/HapticV1/Data/Istex/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002402 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Istex/Corpus/biblio.hfd -nk 002402 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Ticri/CIDE
|area= HapticV1
|flux= Istex
|étape= Corpus
|type= RBID
|clé= ISTEX:7F9073FB9E28EF28B38E74613117D2E9319BDB0D
|texte= Experimental studies on viscofluids for intraocular surgery
}}
| This area was generated with Dilib version V0.6.23. |  |